Dr. Marc Daigneault

Platform Advisory Board  (Infinity)

Dr. Marc Daigneault is a life sciences venture builder specialising in innovation and funding strategy. He has secured over £100 million in public R&D funding across Europe, leveraging it to generate more than £900 million in private investment and corporate partnerships. With a PhD in cellular and molecular biology and expertise in infection and immunology, Marc combines scientific depth with commercial strategy to turn research into scalable ventures. He also serves as an Innovate UK judge for the iCure programme supporting early-stage university spinouts.